plateauing on tirzepatide Plateau: Why It Happens & What Works tirzepatide plateau tirzepatide no longer
Description
Foundayo (Orforglipron) Foundayo is a daily oral GLP-1 weight loss medication approved in 2026
"We aim to ensure patient safety without unnecessarily disrupting essential medication regimens."
PlexusDx's Precision Peptide Genetic Test shows GLP-1 pathway predispositions (GIPR, GLP1R, MC4R variants) that may inform dosing or medication choice
The appetite suppression is strong, and metabolic effects are well-established
[1] Saxenda carries a black triangle symbol () in the UK, indicating it is subject to additional monitoring by the MHRA
Im a doctor in East L.A
